P792:: a rapid clearance blood pool agent for magnetic resonance imaging:: preliminary results

被引:51
作者
Port, M [1 ]
Corot, C [1 ]
Rousseaux, O [1 ]
Raynal, I [1 ]
Devoldere, L [1 ]
Idée, JM [1 ]
Dencausse, A [1 ]
Le Greneur, S [1 ]
Simonot, C [1 ]
Meyer, D [1 ]
机构
[1] Guerbet, Chem Res, F-95943 Roissy, France
关键词
MRI blood pool contrast agent; gadolinium macrocycle; chemistry; relaxivity; pharmacokinetics; acute toxicity;
D O I
10.1016/S1352-8661(01)00108-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
An original MRI contrast agent, called P792, is described. P792 is a gadolinium macrocyclic compound based on a Gd-DOTA structure substituted by hydrophilic arms. The chemical structure of P792 has been optimized in order to provide (1) a high r(1) relaxivity in the clinical field for MRI: 29 mM(-1) x s(-1) at 60 MHz, (2) a high biocompatibility profile and (3) a high molecular volume: the apparent hydrodynamic volume of P792 is 125 times greater than that of Gd-DOTA. As a result of this high molecular volume, P792 presents an unusual pharmacokinetic profile, as it is a Rapid Clearance Blood Pool Agent (RCBPA) characterized by limited diffusion across the normal endothelium. The original pharmacokinetic properties of this RCBPA are expected to be well suited to MR coronary angiography, angiography, perfusion imaging (stress and rest), and permeability imaging (detection of ischemia and tumor grading). Further experimental imaging studies are ongoing to define the clinical value of this compound. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 41 条
[1]   GD-DTPA-CASCADE-POLYMER - POTENTIAL BLOOD-POOL CONTRAST AGENT FOR MR-IMAGING [J].
ADAM, G ;
NEUERBURG, J ;
SPUNTRUP, E ;
MUHLER, A ;
SCHERER, K ;
GUNTHER, RW .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (03) :462-466
[2]  
Bonnemain B, 1998, Ann Pharm Fr, V56, P134
[3]   GD-DOTA - CHARACTERIZATION OF A NEW PARAMAGNETIC COMPLEX [J].
BOUSQUET, JC ;
SAINI, S ;
STARK, DD ;
HAHN, PF ;
NIGAM, M ;
WITTENBERG, J ;
FERRUCCI, JT .
RADIOLOGY, 1988, 166 (03) :693-698
[4]   RATIONALE AND APPLICATIONS FOR MACROMOLECULAR GD-BASED CONTRAST AGENTS [J].
BRASCH, RC .
MAGNETIC RESONANCE IN MEDICINE, 1991, 22 (02) :282-287
[5]   THERMODYNAMIC STUDY OF LANTHANIDE COMPLEXES OF 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID AND 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID [J].
CACHERIS, WP ;
NICKLE, SK ;
SHERRY, AD .
INORGANIC CHEMISTRY, 1987, 26 (06) :958-960
[6]  
Canet EP, 2000, MAGN RESON MED, V43, P403, DOI 10.1002/(SICI)1522-2594(200003)43:3<403::AID-MRM12>3.0.CO
[7]  
2-6
[8]   Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].
Caravan, P ;
Ellison, JJ ;
McMurry, TJ ;
Lauffer, RB .
CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352
[9]   STABILITIES OF TRIVALENT METAL-ION COMPLEXES OF THE TETRAACETATE DERIVATIVES OF 12-MEMBERED, 13-MEMBERED AND 14-MEMBERED TETRAAZAMACROCYCLES [J].
CLARKE, ET ;
MARTELL, AE .
INORGANICA CHIMICA ACTA, 1991, 190 (01) :37-46
[10]   Comparison of two blood pool contrast agents for 0.5-T MR angiography: Experimental study in rabbits [J].
Clarke, SE ;
Weinmann, HJ ;
Dai, EB ;
Lucas, AR ;
Rutt, BK .
RADIOLOGY, 2000, 214 (03) :787-794